Description: Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; and empty hard gelatin capsules. Further, the company menthol crystals, menthol powders and flakes, peppermint oils, dementholized peppermint oils, and menthone; CIS-3 hexenol, CIS-3-hexenol acetate/leaf acetate, and CIS-3-hexenol butyrate; mentha piperita oils, spearmint oils, distilled mentha oils/commint oils, distilled menthofuran, limonene, 3-octanol, terpenes, alpha pinene, beta pinene, 1.8 cineol, and ISO menthol; and menthone glycerol ketal, menthyl acetate, menthyl lactate, terpineol BP/USP/perfumery, pine oils, terpinolene, terpinen 4 ol, terpinyl acetate, lavendor ketone (3-Octanone), 3 menthyl cyclohexenone, and gamma terpinene. Nectar Lifesciences Limited was founded in 1995 and is headquartered in New Delhi, India.
Home Page: www.neclife.com
Himalaya House
New Delhi,
110001
India
Phone:
91 11 4240 3311
Officers
| Name | Title |
|---|---|
| Mr. Sanjiv Goyal | Chairman & MD |
| Dr. Dinesh Dua | Exec. Director |
| Sukriti Saini | Company Sec. |
| Mr. Amit Chadah | Chief Exec. Officer |
| Mr. Sandeep Goel | Chief Financial Officer |
| Mr. Ravi Kant Aggarwal | VP of Accounts |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 327.5 |
| Price-to-Book MRQ: | 0.3574 |
| Price-to-Sales TTM: | 0.1956 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 2002 |